ArticleThe Lancet regional health. Europe2022

Comparison of immunogenicity and clinical effectiveness between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in people with end-stage kidney disease receiving haemodialysis: A prospective, observational cohort study.

Paul Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.